Pfizer/BioNTech, the maker of one of the COVID-19 vaccines, announced that their trial on children ages 5-11 is safe and that the vaccine generated antibodies to the virus. They are expected to submit to the US FDA for emergency use.
Over 2,000 children were given smaller doses (10 versus 30 micrograms) in the trial. Since school has resumed this year, there have been more cases of COVID-19 among children.
According to CNN, more than 28 million additional people will be eligible for the COVID-19 vaccine if the Pfizer vaccine for 5-11 year-olds is approved.